CVE DATABASE / CVE-2015-3113
CVE-2015-3113
Adobe Flash Player Heap-Based Buffer Overflow Vulnerability
Confirmed exploited in the wild. Added 2022-04-13.
Federal remediation due 2022-05-04.
Required action: The impacted product is end-of-life and should be disconnected if still in use.
Summary
Heap-based buffer overflow in Adobe Flash Player before 13.0.0.296 and 14.x through 18.x before 18.0.0.194 on Windows and OS X and before 11.2.202.468 on Linux allows remote attackers to execute arbitrary code via unspecified vectors, as exploited in the wild in June 2015.
CVSS 3.1 breakdown
| Base score | 9.8 (CRITICAL) |
| Vector | CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H |
| Attack vector | NETWORK |
| Attack complexity | LOW |
| Privileges required | NONE |
| User interaction | NONE |
| Scope | UNCHANGED |
| Confidentiality | HIGH |
| Integrity | HIGH |
| Availability | HIGH |
Weakness type (CWE)
Affected products
Use our free CVE Lookup tool for the latest NVD record, or browse the full CISA KEV catalog.
References
- http://lists.opensuse.org/opensuse-security-announce/2015-06/msg00020.html
- http://lists.opensuse.org/opensuse-security-announce/2015-06/msg00025.html
- http://lists.opensuse.org/opensuse-security-announce/2015-07/msg00002.html
- http://marc.info/?l=bugtraq&m=144050155601375&w=2
- http://rhn.redhat.com/errata/RHSA-2015-1184.html
- http://www.securityfocus.com/bid/75371
- http://www.securitytracker.com/id/1032696
- https://bugzilla.redhat.com/show_bug.cgi?id=1235036
- https://bugzilla.suse.com/show_bug.cgi?id=935701
- https://h20564.www2.hpe.com/portal/site/hpsc/public/kb/docDisplay?docId=emr_na-c04952467
- https://helpx.adobe.com/security/products/flash-player/apsb15-14.html
- https://security.gentoo.org/glsa/201507-13
- https://www.suse.com/security/cve/CVE-2015-3113.html
- https://github.com/cisagov/vulnrichment/issues/196
- https://www.cisa.gov/known-exploited-vulnerabilities-catalog?field_cve=CVE-2015-3113
Data: NIST NVD + CISA KEV. NVD last modified 2026-04-21. Always verify against the vendor advisory before acting.